Browsing Category
Ideal Cures
Opportunities and Challenges: Process Raman for the Real-Time Release Testing (RTRT) of…
Abstract
The use of a process analytical technology has been demonstrated using near-infrared spectroscopy for continuous manufacturing of pharmaceutical formulations and is within the scope of the U.S. Food and Drug Administration's real-time release testing initiative. While effective for simple…
Read More...
Read More...
Design, development and scale up studies of metformin hydrochloride multiparticulate system: A…
Metformin hydrochloride (MH) is prescribed for treating diabetes mellitus. The most popular dosage form, viz., tablets has a bulky nature as MH dose ranges up to 1000 mg leading to large size. In geriatric or dysphagic patients, due to altered physiology, swallowing such bulky formulation is…
Read More...
Read More...
pH-dependent pressure-sensitive colonic capsules for the delivery of aqueous bacterial suspensions
Microbiome-based therapies hold great promise for treating various diseases, but the efficient delivery of live bacteria to the colon remains a challenge. Furthermore, current oral formulations, such as lyophilized bacterial capsules or tablets, are produced using processes that can decrease…
Read More...
Read More...
Exploiting common ion addition to accelerate zolpidem hemitartrate release from Eudragit EPO…
The current study aimed at optimizing a previously developed non-clinical formulation for use in zolpidem deprescribing. The formulation under investigation consists of extruded zolpidem hemitartrate (30% w/w) and Eudragit EPO (70% w/w) mixtures which display unsatisfactory dissolution behaviour.…
Read More...
Read More...
Review on Starter Pellets: Inert and Functional Cores
A significant proportion of pharmaceuticals are now considered multiparticulate systems. Modified-release drug delivery formulations can be designed with engineering precision, and patient-centric dosing can be accomplished relatively easily using multi-unit systems. In many cases, Multiple-Unit…
Read More...
Read More...
Colorcon, Inc. Acquires a Majority Share in Ideal Cures Pvt. Ltd., India
Harleysville, Pennsylvania, USA, 14th October 2021, Colorcon, Inc., a global leader in pharmaceutical film coatings and specialty excipients, today announces the purchase of a majority share in Ideal Cures Pvt. Ltd., a manufacturer of excipients and ready-to-use coating systems for solid oral dosage…
Read More...
Read More...
INSTACOAT 4G: Innovative tablet coating formulation
INSTACOATTM 4G is a ready-mixed powder that can be rapidly reconstituted in water, for the film coating of solid oral dosage forms. It contains polymer, plasticizer, pigments, etc. in optimal ratios to achieve significant benefits in terms of processability and product quality.
It is available in…
Read More...
Read More...
INSTACOAT T2F from Ideal Cures
Ideal Cures are continuously innovating to meet their customer’s demands. Responding to customer demand and current market trend of clean label ingredients, Ideal Cures launched a new product: Talc and Titanium dioxide free coating Instacoat T2F.
INSTACOAT T2F is a novel ready-to-use Titanium…
Read More...
Read More...
Application of Design Space, Uncertainty, and Risk Profile Strategies to the Development and…
Background: Counterfeit medicines are an increasing scourge that are difficult to identify and they have become industrialized and widespread through highly organized illegal channels.
Objective: This research aims to develop a robust method to determine four phosphodiesterase type-5 inhibitors…
Read More...
Read More...
Do we need to replace Titanium Dioxide in Pharmaceutical Formulations?
Update from October 7th: News on EU commission's decision:
On what have the member states voted on 7 October and what are the next steps?
"The Member States have expressed a favourable opinion, in the context of a Standing Committee on Plants, Animals, Food and Feed, on a proposal by the European…
Read More...
Read More...